Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Active, not recruiting · NCT02547987 · Registry updated 2025-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2025-03-12 | NCT02547987 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mothaffar Rimawi | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harris Health System Smith Clinic | Houston | United States | 1 |
| Lester & Sue Smith Breast Center at Baylor College of Medicine | Houston | United States | 1 |
| TriHealth Hatton Research | Cincinnati | United States | 1 |